Cerebral Therapeutics
Aurora, US · Delaware corporation
Biotech
Founders & leadership
DA
Daniel AbramsChief Executive Officer
WL
Warren LammertNamed on SEC filing
SF
Stephen FarrNamed on SEC filing
MS
Mahendra ShahNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$31M disclosed across 2 rounds · 2018–2020
▶$20MraisedJan 2020 · 6 investors · Other Health CareRule 506(b)
▶$20MraisedJan 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel AbramsExecutive Officer, Director
- Shah MahendraDirector
- Warren LammertDirector
- Stephen FarrDirector
- Weston NicholsDirector
- Matthew HammondDirector
- Offering amount
- $35M
- Amount sold
- $20M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedMar 2019 · 4 investors · PharmaceuticalsRule 506(b)
▶$11MraisedMar 2019 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Warren LammertDirector
- Stephen FarrDirector
- Mahendra ShahDirector
- Daniel AbramsExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $11M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cerebral Therapeutics raised?
- Cerebral Therapeutics has disclosed $31M raised across 2 rounds.
- Where is Cerebral Therapeutics headquartered?
- Cerebral Therapeutics is headquartered in Aurora, US.